Senti Biosciences adjourns annual meeting to gather more merger votes
The company postponed its October 8 meeting without business and will reconvene October 15 to continue soliciting stockholder support for a merger proposal.
Senti Biosciences Holdings, Inc. convened its virtual 2026 Annual Meeting of Stockholders on October 8, 2026, and adjourned the meeting without conducting any business.1
A quorum was present, but the company adjourned the meeting to allow more time to solicit stockholder votes in favor of the Merger Agreement Proposal, as defined in the definitive proxy statement filed on September 24, 2026.1 The meeting will be reconvened on Thursday, October 15, 2026, at 8:00 a.m. Pacific time, held virtually at www.virtualshareholdermeeting.com/SNTI2026.1
No changes have been made to the proposals to be voted on by stockholders, and all polls will remain open.1 The record date for the annual meeting remains September 23, 2026.1 Stockholders who have already submitted or otherwise cast their proxy and do not wish to change their vote do not need to take further action.1
The filing states that the company is encouraging stockholders to read the proxy statement and other related materials, which are available free of charge on the SEC's website, and to vote on each proposal.1
The 8-K also notes that the filing may be considered solicitation material related to the reconvened meeting, and the company has filed the proxy statement with the SEC in connection with it.1 Senti's directors and executive officers may be deemed participants in the proxy solicitation for the meeting.1 The report was signed by Chief Executive Officer Timothy Lu on October 13, 2026.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.